HK1029117A1 - New spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

New spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
HK1029117A1
HK1029117A1 HK00108451A HK00108451A HK1029117A1 HK 1029117 A1 HK1029117 A1 HK 1029117A1 HK 00108451 A HK00108451 A HK 00108451A HK 00108451 A HK00108451 A HK 00108451A HK 1029117 A1 HK1029117 A1 HK 1029117A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
spiro
new
Prior art date
Application number
HK00108451A
Other languages
English (en)
Inventor
Alex Cordi
Mark Millan
Adrian Newman-Tancredi
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1029117A1 publication Critical patent/HK1029117A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00108451A 1998-12-18 2000-12-28 New spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them. HK1029117A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9816000A FR2787450B1 (fr) 1998-12-18 1998-12-18 Nouveaux derives spiroimidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1029117A1 true HK1029117A1 (en) 2001-03-23

Family

ID=9534134

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108451A HK1029117A1 (en) 1998-12-18 2000-12-28 New spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (22)

Country Link
US (1) US6172097B1 (xx)
EP (1) EP1010694B1 (xx)
JP (1) JP3457241B2 (xx)
KR (1) KR100472522B1 (xx)
CN (1) CN1149201C (xx)
AT (1) ATE246680T1 (xx)
AU (1) AU760373B2 (xx)
BR (1) BR9905904A (xx)
CA (1) CA2292920C (xx)
DE (1) DE69910156T2 (xx)
DK (1) DK1010694T3 (xx)
EA (1) EA002979B1 (xx)
ES (1) ES2205741T3 (xx)
FR (1) FR2787450B1 (xx)
HK (1) HK1029117A1 (xx)
HU (1) HU225820B1 (xx)
NO (1) NO314402B1 (xx)
NZ (1) NZ501890A (xx)
PL (1) PL202368B1 (xx)
PT (1) PT1010694E (xx)
SI (1) SI1010694T1 (xx)
ZA (1) ZA997735B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
CA2716080C (en) 2008-02-20 2016-12-13 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294185B1 (en) * 1993-03-12 2001-09-25 Auburn University Monomeric and polymeric cyclic amine and N-halamine compounds
FR2707982B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2709306B1 (fr) * 1993-07-20 1995-10-20 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
KR100472522B1 (ko) 2005-03-07
SI1010694T1 (en) 2003-12-31
AU760373B2 (en) 2003-05-15
ATE246680T1 (de) 2003-08-15
AU6529199A (en) 2000-06-22
BR9905904A (pt) 2000-08-29
HU225820B1 (en) 2007-10-29
EA199901049A3 (ru) 2000-08-28
DE69910156T2 (de) 2004-06-09
HUP9904629A2 (hu) 2000-08-28
NO996285D0 (no) 1999-12-17
NO996285L (no) 2000-06-19
EP1010694A3 (fr) 2000-07-26
JP3457241B2 (ja) 2003-10-14
CA2292920C (fr) 2004-01-27
HU9904629D0 (en) 2000-02-28
CN1149201C (zh) 2004-05-12
NZ501890A (en) 2001-03-30
KR20000067830A (ko) 2000-11-25
ZA997735B (en) 2000-06-19
PL337265A1 (en) 2000-06-19
DE69910156D1 (de) 2003-09-11
EA002979B1 (ru) 2002-12-26
JP2000178257A (ja) 2000-06-27
US6172097B1 (en) 2001-01-09
HUP9904629A3 (en) 2000-12-28
CA2292920A1 (fr) 2000-06-18
ES2205741T3 (es) 2004-05-01
EP1010694B1 (fr) 2003-08-06
CN1264704A (zh) 2000-08-30
EA199901049A2 (ru) 2000-08-28
EP1010694A2 (fr) 2000-06-21
PL202368B1 (pl) 2009-06-30
NO314402B1 (no) 2003-03-17
FR2787450A1 (fr) 2000-06-23
DK1010694T3 (da) 2003-11-24
PT1010694E (pt) 2003-10-31
FR2787450B1 (fr) 2001-01-26

Similar Documents

Publication Publication Date Title
AU617918B2 (en) 2-aminopyrimidinone derivatives
PH30916A (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same.
AU6307290A (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
LU91076I9 (en) 4&#34;-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP0902007A4 (en) CHALCON DERIVATIVES AND MEDICINES THAT CONTAIN THEM
GR3031500T3 (en) NOVEL 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
AU5795694A (en) New bicyclic nitrogen compounds, process for preparing them and pharmaceutical compositions containing them
IL106445A0 (en) 4-substituted 1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
ZA997734B (en) Imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.
HU9402466D0 (en) Indole derivatives as steroid-5-alpha-reductase inhibitors
HK1029117A1 (en) New spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.
AU4842297A (en) New N-benzylpiperazine compounds, process for their preparation and the pharmaceutical compositions which contain them
AU4084889A (en) Antihypertensive 3-piperidinyl-indazole derivatives
EP1227098A4 (en) TRIAZOLPURINE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THEM AND MEANS THAT SHOW AFFINITY TO THE ADENOSINE A3 RECEPTOR
HUT65376A (en) Process for preparing n,n&#39;,n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient
AU1528292A (en) New urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101217